slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 84,271-84,300
Pages 3,683
Rows per page 30
Component
84,271-84,300 of 110,471
14
The slide outlines a strategic partnership as a solution to scale operations and meet financial targets.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
15
Includes a reconciliation of reported vs adjusted figures and specific commentary on segment performance and operational challenges.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
17
Benson Hill | Results Presentation Deck | 27 slidesBenson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · Action1 hit
18
The slide uses a hub-and-spoke style diagram to connect strategic pillars (Growth, Margin, Cash, Tech, Execution) to specific financial targets.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · Action1 hit
19
The slide uses a numbered list paired with a comparison table to illustrate competitive moats.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · Action1 hit
21
The table provides a bridge between reported figures and adjusted figures excluding mark-to-market timing differences.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · Action1 hit
05
The slide uses a comparative visual framework to contrast healthy cells (no binding) with cancer cells (CAB binding).BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
06
The slide uses a three-column layout to categorize the platform's therapeutic modalities.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations 1 hit
10
Includes waterfall plot for partial response and spider plot for longitudinal tumor change.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
12
Includes a spider plot for lesion change and a Kaplan-Meier survival curve.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
13
Includes Kaplan-Meier survival curve and waterfall plot for lesion change.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
14
Clinical trial data showing PFS at 3 months for Liposarcoma and Synovial Sarcoma cohorts.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
15
Includes specific clinical trial terminology (CTCAE, SAE, RP2D, Q2W).BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
16
The slide uses a grid of metrics to establish the total addressable market and clinical benchmarks.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
17
The chart is a waterfall plot showing maximum change from baseline for different patient cohorts.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
20
Clinical trial data presentation for oncology drug candidate.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
23
The chart is a waterfall plot showing percentage change in tumor size for individual patients.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
24
The slide uses a 2x2 grid of metrics to frame the market problem, followed by specific target population and success threshold data.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
26
SCCHN = Squamous Cell Carcinoma of the Head and Neck. ROR2 is the target biomarker.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
33
The chart shows tumor volume over time for three different antibody treatments, with the CAB-EpCAM x CAB-CD3 showing the best efficacy.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations 1 hit
03
Standard pharmaceutical regulatory disclosure slide.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations 1 hit
05
Standard pharmaceutical safety disclosure slide.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations 1 hit
08
The slide uses a structured grid layout to categorize key performance indicators.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Loop · Golden Circle1 hit
10
The slide highlights organizational scale and diversity metrics as of Dec 31, 2021.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Loop · Golden Circle1 hit
17
Includes product image and key performance metrics.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
21
The diagram illustrates a circular, iterative process (flywheel) connecting patient samples and variability to specific drug classes.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
03
This is a standard pharmaceutical regulatory disclosure slide.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
06
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
12
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
19
Includes a citation to a Nature Medicine paper and a pipeline table.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit